Hoping your company will begin paying for anti-obesity medications like Wegovy? You may be in luck. A growing number of employers are considering covering the blockbuster weight-loss drugs ...

QUESTION: A family member had recurring episodes of atrial fibrillation that were about to lead to potentially dangerous ...

It’s something that I know in my heart helped me.” The drug’s effects were studied for three years in the trial, however breast cancer can recur decades after diagnosis. “It would be ...

Sanofi’s Enjaymo, the only approved drug therapy for a rare and debilitating blood disorder, is being acquired by Recordati in a deal that helps the Italian company build its rare disease ...

A top California health plan is set to offer one of the world’s biggest-selling drugs for free in a bid to show the medicine can reach Americans affordably without going through the middlemen ...

The Sinaloa and Jalisco New Generation cartels "are at the heart" of a synthetic drugs crisis in the United States, according to the US Drug Enforcement Administration (DEA). The two cartels are ...

AstraZeneca has paid CSPC Pharmaceutical Group $100 million for a preclinical cardiovascular disease drug. The deal, which covers a potential rival to an Eli Lilly prospect, positions AstraZeneca ...

Certain blockbuster weight-loss drugs have been found to protect the heart in significant ways, and new research suggests that the cardiovascular benefits could extend to an even broader set of ...

Share on Pinterest GLP-1 drugs like Ozempic and Wegovy may help reduce the risk of cardiovascular disease and prevent more than 34,000 heart attacks and strokes a year. Iparraguirre Recio/Getty ...